Long, G. V., Davar, D., Hamid, O., Olson, D. J., Sato, T., Lopez, J. S., Lebbé, C., Bechter, O. E., Kapiteijn, E., Schoenfeld, A. J., Hall, E. T., Shaw, H. M., Izar, B., Thistlethwaite, F., Peck, F., Kirk, P., Yuan, Y., Marshall, S., Williams, A. (2026). Phase 1 evaluation of the PRAME-targeted ImmTAC brenetafusp in advanced melanoma (Mel).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9527